These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10471602)

  • 1. Bronchodilator effect of inhaled olprinone, a phosphodiesterase 3 inhibitor, in asthmatic patients.
    Myou S; Fujimura M; Kamio Y; Ishiura Y; Tachibana H; Hirose T; Hashimoto T; Matsuda T
    Am J Respir Crit Care Med; 1999 Sep; 160(3):817-20. PubMed ID: 10471602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchodilator effects of intravenous olprinone, a phosphodiesterase 3 inhibitor, with and without aminophylline in asthmatic patients.
    Myou S; Fujimura M; Kamio Y; Hirose T; Kita T; Tachibana H; Ishiura Y; Watanabe K; Hashimoto T; Nakao S
    Br J Clin Pharmacol; 2003 Apr; 55(4):341-6. PubMed ID: 12680881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
    Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
    Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
    Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
    Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the bronchodilator effect of inhaled furosemide compared to salbutamol in asthmatic patients.
    Rodríguez Vázquez JC; Pino Alfonso PP; Gassiot Nuño C; Paez Prats I; Fernández Manzano E
    J Investig Allergol Clin Immunol; 1998; 8(2):115-8. PubMed ID: 9615306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma.
    Szczeklik A; Mastalerz L; Nizankowska E; Cmiel A
    Am J Respir Crit Care Med; 1996 Feb; 153(2):567-71. PubMed ID: 8564099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aerosolized administration of KF19514, a phosphodiesterase 4 inhibitor, on bronchial hyperresponsiveness and airway inflammation induced by antigen inhalation in guinea-pigs.
    Myou S; Fujimura M; Kurashima K; Tachibana H; Hirose T; Nakao S
    Clin Exp Allergy; 2000 May; 30(5):713-8. PubMed ID: 10792364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.
    Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the bronchodilator effect of salbutamol inhaled via Turbuhaler as two consecutive doses or as two divided doses at different time intervals.
    Lindbladh C; Smith P; Jackson L; Begishvilli B; Jamieson A; Holgate ST
    Int J Pharm; 1999 Nov; 190(1):57-62. PubMed ID: 10528097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma.
    Brieva JL; Danta I; Wanner A
    Am J Respir Crit Care Med; 2000 Jan; 161(1):293-6. PubMed ID: 10619834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilatory effect of inhaled versus oral salbutamol in bronchial asthma.
    Louridas G; Kakoura M; Galanis N; Patakas D; Kastritsi K
    Respiration; 1983; 44(6):439-43. PubMed ID: 6648053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J; Ankerst J
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of procaterol and salbutamol in single inhaled doses].
    Crespo Notario JA; Sobradillo Peña V; Garnacho López E; Ansola Zubiaurre PM; Mazo Echániz J
    Rev Clin Esp; 1989 Apr; 184(6):297-301. PubMed ID: 2526959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG; Earnshaw JS; Palmer JB
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily].
    Ringbaek TJ; Søes-Petersen U; Christensen M; Iversen ET; Rasmussen FV
    Ugeskr Laeger; 1996 Jul; 158(27):3940-3. PubMed ID: 8701511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilator effects of exercise hyperpnea and albuterol in mild-to-moderate asthma.
    Milanese M; Saporiti R; Bartolini S; Pellegrino R; Baroffio M; Brusasco V; Crimi E
    J Appl Physiol (1985); 2009 Aug; 107(2):494-9. PubMed ID: 19541736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.